Literature DB >> 6541311

A neurologic rating scale (NRS) for use in multiple sclerosis.

J C Sipe, R L Knobler, S L Braheny, G P Rice, H S Panitch, M B Oldstone.   

Abstract

A neurologic rating scale (NRS) has been developed for clinical assessment of MS patients. The scale has been tested on 250 MS patients. Assignment of the NRS score is based on assessment of each component of the neurologic examination and accurately reflects overall neurologic function. Clinical exacerbations are evident as significant deviations from baseline scores. There was close interexaminer correlation, with the range of variability no greater than 2.6%. The NRS is a simple, reliable, and sensitive scale that can be used with other objective measurements of neurologic function, such as neurophysiologic studies, in the clinical assessment of MS patients.

Entities:  

Mesh:

Year:  1984        PMID: 6541311     DOI: 10.1212/wnl.34.10.1368

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  40 in total

1.  Cerebrospinal fluid analysis differentiates between relapsing-remitting and secondary progressive multiple sclerosis.

Authors:  P J Jongen; K J Lamers; W H Doesburg; W A Lemmens; O R Hommes
Journal:  J Neurol Neurosurg Psychiatry       Date:  1997-10       Impact factor: 10.154

2.  Assessing relapses and response to relapse treatment in patients with multiple sclerosis: a nursing perspective.

Authors:  Amy Perrin Ross; June Halper; Colleen J Harris
Journal:  Int J MS Care       Date:  2012

Review 3.  More immunotherapy for multiple sclerosis.

Authors:  R A Hughes; B Sharrack
Journal:  J Neurol Neurosurg Psychiatry       Date:  1996-09       Impact factor: 10.154

4.  A comparison of two neurologic scoring instruments for multiple sclerosis.

Authors:  J A Koziol; A Frutos; J C Sipe; J S Romine; E Beutler
Journal:  J Neurol       Date:  1996-03       Impact factor: 4.849

5.  Autologous nonmyeloablative hematopoietic stem cell transplantation for neuromyelitis optica.

Authors:  Richard K Burt; Roumen Balabanov; Xiaoqiang Han; Carol Burns; Joseph Gastala; Borko Jovanovic; Irene Helenowski; Jiraporn Jitprapaikulsan; James P Fryer; Sean J Pittock
Journal:  Neurology       Date:  2019-10-02       Impact factor: 9.910

6.  Effect of Nonmyeloablative Hematopoietic Stem Cell Transplantation vs Continued Disease-Modifying Therapy on Disease Progression in Patients With Relapsing-Remitting Multiple Sclerosis: A Randomized Clinical Trial.

Authors:  Richard K Burt; Roumen Balabanov; Joachim Burman; Basil Sharrack; John A Snowden; Maria Carolina Oliveira; Jan Fagius; John Rose; Flavia Nelson; Amilton Antunes Barreira; Kristina Carlson; Xiaoqiang Han; Daniela Moraes; Amy Morgan; Kathleen Quigley; Kimberly Yaung; Regan Buckley; Carri Alldredge; Allison Clendenan; Michelle A Calvario; Jacquelyn Henry; Borko Jovanovic; Irene B Helenowski
Journal:  JAMA       Date:  2019-01-15       Impact factor: 56.272

7.  Problems with rating scales for multiple sclerosis: a novel approach--the CAMBS score.

Authors:  C J Mumford; A Compston
Journal:  J Neurol       Date:  1993       Impact factor: 4.849

8.  The treatment of chronic progressive multiple sclerosis with cladribine.

Authors:  E Beutler; J C Sipe; J S Romine; J A Koziol; R McMillan; J Zyroff
Journal:  Proc Natl Acad Sci U S A       Date:  1996-02-20       Impact factor: 11.205

9.  Adaptive robot training for the treatment of incoordination in Multiple Sclerosis.

Authors:  Elena Vergaro; Valentina Squeri; Giampaolo Brichetto; Maura Casadio; Pietro Morasso; Claudio Solaro; Vittorio Sanguineti
Journal:  J Neuroeng Rehabil       Date:  2010-07-29       Impact factor: 4.262

10.  Novel composite MRI scale correlates highly with disability in multiple sclerosis patients.

Authors:  Peter Kosa; Mika Komori; Ryan Waters; Tianxia Wu; Irene Cortese; Joan Ohayon; Kaylan Fenton; Jamie Cherup; Tomas Gedeon; Bibiana Bielekova
Journal:  Mult Scler Relat Disord       Date:  2015-08-28       Impact factor: 4.339

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.